The sodium-glucose co-transporter 2 inhibitor velagliflozin reduces hyperinsulinemia and prevents laminitis in insulin-dysregulated ponies.

PLoS One · 2018 · PMC6136744 · PMID 30212530

Europe PMC DOI

hedged sentence

0.0630

closest p · 1.3× alpha

0.0630

boldest claim

The sentences

showed a trendP = 0.063so close (0.05 < p ≤ 0.1)

Baseline 0800 h insulin concentrations (0 min DCP sample) also showed a trend towards being lower in treated ponies (P = 0.063), with a median (IQR) value of 8 μIU/mL (4–95) compared to 52 μIU/mL (10–189) for controls.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.